Commentary - (2025) Volume 10, Issue 3
Received: 02-Jun-2025, Manuscript No. cgj-26-186518;
Editor assigned: 04-Jun-2025, Pre QC No. P-186518;
Reviewed: 18-Jun-2025, QC No. Q-186518;
Revised: 23-Jun-2025, Manuscript No. R-186518;
Published:
30-Jun-2025
, DOI: 10.37421/2952-8518.2025.10.314
Citation: Al-Hassan, Fatima. ”Endoscopic Ultrasound: Key for Pancreatic and Biliary Diagnosis.” Clin Gastroenterol J 10 (2025):314.
Copyright: © 2025 Al-Hassan F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Endoscopic ultrasound (EUS) stands as an indispensable modality in the comprehensive evaluation of pancreatic and biliary disorders, offering unparalleled high-resolution imaging capabilities and the crucial ability to perform fine-needle aspiration (FNA) or biopsy for precise tissue diagnosis. Its proficiency extends to the detailed characterization of both pancreatic cystic and solid lesions, providing critical insights into their nature. Furthermore, EUS plays a pivotal role in the staging of pancreatic cancer by accurately assessing local invasion and the involvement of regional lymph nodes, thereby informing strategic treatment planning. EUS is also instrumental in guiding a variety of interventional procedures, demonstrating its therapeutic utility, such as in the effective drainage of pancreatic pseudocysts. In the realm of biliary disorders, its diagnostic acumen is particularly valuable for identifying choledocholithiasis, especially in instances where conventional imaging modalities yield inconclusive results. This technique is also essential for the thorough evaluation of malignant biliary strictures, aiding in their diagnosis and management. More specifically, EUS-guided fine-needle biopsy (FNB) has rapidly emerged as a powerful and highly effective technique for acquiring adequate tissue samples essential for histopathological analysis. This is particularly critical in the diagnosis and detailed characterization of pancreatic cancer, offering a more definitive diagnostic pathway. Advancements in EUS technology, including the development of novel FNB needles featuring different cutting mechanisms and the capacity for larger sample volumes, have significantly enhanced diagnostic yield. This improvement translates into a reduced need for repeat procedures, thereby optimizing patient management and streamlining the diagnostic process. The critical role of EUS in differentiating benign from malignant pancreatic cystic neoplasms cannot be overstated, as this distinction is paramount for guiding appropriate treatment strategies. Features meticulously evaluated by EUS, such as lesion size, the presence of septations, mural nodules, and ductal communication, are key indicators in this diagnostic differentiation. These EUS findings are often complemented by cyst fluid analysis, further refining the diagnostic accuracy and providing a more comprehensive understanding of the lesion's nature. This integrated approach is vital for making informed therapeutic decisions. EUS is also instrumental in the accurate staging of pancreatic cancer, with a particular emphasis on assessing the involvement of regional lymph nodes and the vascular anatomy surrounding the tumor. Understanding the extent of vascular involvement is crucial as it directly influences surgical resectability and the overall treatment planning for pancreatic cancer patients. The ability of EUS to visualize peripancreatic structures provides an exceptional level of detail that often surpasses that of conventional cross-sectional imaging techniques, offering a more complete anatomical assessment. Beyond diagnosis and staging, EUS-guided interventions have become well-established procedures offering minimally invasive therapeutic options for patients suffering from various pancreatic disorders. Procedures such as pseudocyst drainage and celiac plexus neurolysis are prime examples of EUSâ??s therapeutic capabilities. These interventions not only provide relief from debilitating symptoms but also contribute to a significant reduction in overall complications associated with these conditions. In the context of biliary strictures, EUS plays a vital role in the challenging task of differentiating between benign and malignant causes, particularly when the stricture is not clearly visualized by more conventional imaging methods. Finally, EUS has demonstrated high efficacy in the detection and characterization of choledocholithiasis, especially for small or impacted stones that might otherwise be missed by other imaging modalities, and can also guide subsequent therapeutic interventions like stone extraction, solidifying its comprehensive utility [1].
Endoscopic ultrasound (EUS) serves as a cornerstone in the diagnostic armamentarium for pancreatic and biliary disorders, providing high-resolution imaging that facilitates accurate characterization of lesions. Its capacity for fine-needle aspiration (FNA) or biopsy is essential for obtaining tissue for definitive diagnosis, a critical step in patient management. EUS excels in delineating the features of pancreatic cystic and solid lesions, offering insights into their nature and potential for malignancy. Furthermore, its role in the staging of pancreatic cancer is profound, enabling precise assessment of local invasion and lymph node involvement, which are critical determinants for treatment planning and surgical candidacy. EUS is also indispensable for guiding various interventional procedures, including the drainage of pancreatic pseudocysts, offering a less invasive therapeutic alternative. In the evaluation of biliary pathology, EUS proves invaluable for diagnosing conditions such as choledocholithiasis, particularly when other imaging modalities are equivocal, and for characterizing malignant biliary strictures. The advent of EUS-guided fine-needle biopsy (FNB) has significantly advanced the diagnostic capabilities for pancreatic cancer. Novel FNB needles designed to maximize tissue acquisition have improved diagnostic yields, reducing the necessity for repeat procedures and directly impacting patient care pathways. The differentiation between benign and malignant pancreatic cystic neoplasms is a critical decision point in management, and EUS plays a central role in this assessment. Features such as lesion size, the presence of septations, mural nodules, and the degree of communication with the pancreatic duct, as visualized by EUS, are key discriminators. These findings are often integrated with cyst fluid analysis for a more robust diagnosis. EUS also contributes significantly to the staging of pancreatic cancer by meticulously evaluating regional lymph node status and the extent of vascular involvement, factors that heavily influence surgical decisions and overall treatment strategies. Its ability to visualize peripancreatic structures in detail offers a comprehensive anatomical understanding that often complements or surpasses conventional cross-sectional imaging. EUS-guided interventions, including pseudocyst drainage and celiac plexus neurolysis, represent important therapeutic applications, offering minimally invasive options for symptom management and complication reduction in patients with pancreatic disorders. In the context of biliary strictures, EUS is crucial for distinguishing between benign and malignant causes, especially when conventional imaging is limited. EUS-FNA can provide tissue for a definitive histological diagnosis, resolving diagnostic ambiguities. Additionally, EUS is highly effective in detecting and characterizing choledocholithiasis, particularly for small or difficult-to-visualize stones, and can guide stone extraction. The characterization of intraductal papillary mucinous neoplasms (IPMNs) is also significantly enhanced by EUS, aiding in the assessment of mural nodules and ductal dilatation to inform surgical decisions. EUS elastography is an emerging technique that adds information about tissue stiffness, potentially improving the differentiation of pancreatic lesions. Finally, EUS is essential for the surveillance of pancreatic cysts, monitoring for changes that may indicate malignant transformation [1].
Endoscopic ultrasound (EUS) is a vital tool for assessing pancreatic and biliary disorders, offering high-resolution imaging and tissue diagnosis through fine-needle aspiration/biopsy. It excels in characterizing pancreatic lesions, staging pancreatic cancer, and guiding interventions like pseudocyst drainage. For biliary issues, EUS aids in diagnosing choledocholithiasis and evaluating malignant strictures. EUS-guided fine-needle biopsy (FNB) improves diagnostic yield for pancreatic cancer. Differentiating benign from malignant pancreatic cysts and staging pancreatic cancer are key applications, assessing lesion features and vascular involvement. EUS-guided procedures offer minimally invasive therapeutic options, and EUS elastography provides complementary information on tissue stiffness. It's also crucial for monitoring pancreatic cysts for malignant changes.
None
None
Clinical Gastroenterology Journal received 33 citations as per Google Scholar report
